HomeScreenerMRKProfile
F
34/100

Merck & Co

MRKOncology/Vaccines
📋
Analyst Summary
✓ VERIFIED2026-04-11

Merck & Co (MRK) is the lead sponsor of 200 active clinical trials listed on ClinicalTrials.gov[4], including 91 Phase 3[1], 76 Phase 2[2], 70 Phase 1[3].

Trial NCT06655883[5] evaluates Suvorexant in Insomnia with a target enrollment of 300 participants. Trial NCT05173987[6] evaluates pembrolizumab in Endometrial Neoplasms with a target enrollment of 280 participants. Trial NCT06074588[7] evaluates Sacituzumab tirumotecan in Non-small Cell Lung Cancer (NSCLC) with a target enrollment of 556 participants.

MRK has 3 Form 4 insider filings recorded at the SEC in the past 30 days[8].

Sources

  1. ClinicalTrials.gov (2026-04-11)
  2. ClinicalTrials.gov (2026-04-11)
  3. ClinicalTrials.gov (2026-04-11)
  4. ClinicalTrials.gov (2026-04-11)
  5. ClinicalTrials.gov · NCT06655883 (2026-04-06)
  6. ClinicalTrials.gov · NCT05173987 (2024-11-21)
  7. ClinicalTrials.gov · NCT06074588 (2026-02-13)
  8. SEC EDGAR · 0000310158 (2026-04-11)
🔬
Clinical Trials
200
NCT02332668Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma, Microsatellite-instability-high Solid Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT02362594Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT02628067Advanced Cancer, Anal Carcinoma, Anal Cancer, Biliary Cancer, Cholangiocarcinoma, Bile Duct Cancer, Neuroendocrine Tumor, Carcinoid Tumor, Endometrial Carcinoma, Endometrial Cancer, Cervical Carcinoma, Cervical Cancer, Vulvar Carcinoma, Vulvar Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Mesothelioma, Thyroid Carcinoma, Thyroid Cancer, Salivary Gland Carcinoma, Salivary Gland Cancer, Salivary Cancer, Parotid Gland Cancer, Advanced Solid Tumors, Colorectal Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT02653118Cervical Cancer, Vulvar Cancer, Vaginal Cancer, Genital Warts, Human Papillomavirus Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT02861573Metastatic Castration-Resistant Prostate Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03162536Lymphoma, B-Cell, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma, Richter's Transformation, Follicular Lymphoma, Marginal Zone Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03407144Hodgkin Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03425643Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03486873Solid Tumors, Hematologic Malignancies
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03553836Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03711032High-risk Non-muscle Invasive Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03725059Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03740165Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03742895Advanced Solid Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03765918Head and Neck Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03834493Prostatic Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03924856Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03924895Urinary Bladder Cancer, Muscle-invasive
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT03998254Papillomavirus Infections
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04123366Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04165070Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04165798Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04191096Metastatic Hormone-Sensitive Prostate Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04195750Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04199689Papillomavirus Infections
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04210115Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04305054Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04380636Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04489771Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04586231Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04624204Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04626479Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04626518Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04662710Advanced/Metastatic Gastroesophageal Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04665037Invasive Fungal Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04708041Papillomavirus Infections
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04736706Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04776252HIV-1 Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04846920Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04895722Colorectal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04938817Small Cell Lung Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04949256Metastatic Esophageal Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04956692Non-Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04976634Neoplasm Malignant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04980872PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05017012Advanced or Metastatic Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05030506Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05067283Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05139017DLBCL, Diffuse Large B-Cell Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05144841Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05173987Endometrial Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05224141Small Cell Lung Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05239728Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05239741Colorectal Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05285826Papillomavirus Infections
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05298423Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05314023Genital Warts
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05319730Esophageal Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05347225Hematological Malignancies
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05382325Advanced or Metastatic Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05406401Lymphoma, Large B-Cell, Diffuse (DLBCL)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05450705Papillomavirus Infections
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05468697Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05562830Urothelial Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05587712Pulmonary Arterial Hypertension
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05609968Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05612035Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05624554Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05630755HIV-1 Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05631093HIV-1 Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05705349HIV-1 Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05714085Heart Failure, Left Ventricular Systolic Dysfunction
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05722015Metastatic Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05766501HIV Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05845814Metastatic Urothelial Carcinoma, Urothelial Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05853367Metastatic Solid Tumors, Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05899049Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05933577Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05947851Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma, Lymphoma, Small Lymphocytic, CLL, SLL
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06008756Arteriosclerosis, Hypercholesterolaemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06041802Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06049212Non-small Cell Lung Cancer, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1), Programmed Cell Death 1 Ligand 1(PDL1, PD-L1), Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06052059Ulcerative Colitis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06074588Non-small Cell Lung Cancer (NSCLC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06077760Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06079879Essential Thrombocythemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06099782Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06104449Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06132958Endometrial Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06136559Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06136624Prostate Cancer Metastatic
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06136650Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06212752Metastatic Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06305754Non-small Cell Lung Cancer (NSCLC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06305767Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06307431Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06312137Non Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06312176Breast Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06345729Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06353386Prostatic Neoplasms, Castration-Resistant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06356311Gastroesophageal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06393374Triple-Negative Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma, Ewing Sarcoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06422143Non-small Cell Lung Cancer, NSCLC
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06428396Metastatic Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06428409Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06430801Crohn's Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06442436Hepatic Impairment (HI)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06460961Neoplasm Metastasis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06465186Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, NAFLD, Metabolic Dysfunction-associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06469944Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06483334Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06492291Hypercholesterolemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06504394Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Primary Mediastinal Large B-cell Lymphoma Recurrent, Primary Mediastinal Large B-cell Lymphoma Refractory
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06580587Healthy, HIV Pre-exposure Prophylaxis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06596694Gastrointestinal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06623409Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06623422Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06637423Non-Muscle Invasive Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06651281Crohn Disease, Colitis, Ulcerative
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06655324Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06655883Insomnia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06667700Coronavirus Disease (COVID-19)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06686394Breast Neoplasms, Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06688058Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06717347Diffuse Large B-Cell Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06731907Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06780085Carcinoma, Non-Small-Cell Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06780098Lung Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06780111Esophageal Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06780137Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06788912Lung Neoplasm Malignant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06797635Breast Neoplasms, Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06814145Hypertension, Pulmonary
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06818643Advanced Solid Tumors, Malignant Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06824467Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06841354Triple Negative Breast Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06843447Ovarian Cancer Recurrent
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06863272Castration-Resistant Prostatic Cancer, Metastasis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06890884Lymphoma, Large B-Cell, Diffuse
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06891066Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06925737Prostate Cancer, Prostatic Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06925750Pulmonary Arterial Hypertension
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06941272Malignant Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06952504Endometrial Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06956235Hidradenitis Suppurativa
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07013487Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07030712Metastatic Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07033494Early Alzheimer's Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07042945HIV Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07044297Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07049926Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07058077Heterozygous Familial Hypercholesterolemia (HeFH)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07060807Breast Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07071623Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07089784Diabetes Mellitus, Type 2
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07133633Radiographic Axial Spondyloarthritis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07168915Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07176390Arthritis, Rheumatoid
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07190248Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07199465Cytomegalovirus Prophylaxis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07209111Neoplasm Malignant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07216482Hyperlipidemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07216703Cervical Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07218029Pulmonary Arterial Hypertension
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07219550Healthy, Hepatic Impairment
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07221474Squamous Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07222488Bladder Cancer, Urinary Bladder Neoplasms
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07227402Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07227597Small Cell Lung Cancer Extensive Stage
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07232589Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07232602Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07247110Malignant Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07252739Malignant Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07266818Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07266831Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07286149Lung Neoplasm Malignant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07300267Pneumococcal Infection
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07300280Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07302347Malignant Neoplasm, Carcinoma, Merkel Cell, Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07305831Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07318558Ovarian Neoplasms, Ovarian Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07334860Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07348237Chronic Kidney Failure, End-Stage Renal Disease, Renal Impairment
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07388667Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07405151Oesophageal Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07405164Von Hippel-Lindau Disease, Carcinoma, Renal Cell
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07405177Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07419295Bladder Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07431827Non-small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07431866Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07435194Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07481708Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
3 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Data Provenance
cik1 verified
clinical trial200 verified
insider buy1 verified
trial count4 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR